Advanced
technology. Exacting standards.
Company Overview
Implant Sciences Corporation (IMSC:OTCPK) develops
and commercializes explosives trace detection (ETD) solutions for
transportation and aviation security, force protection and law
enforcement, critical infrastructure protection, and public safety
markets.
Founded in 1984, Implant Sciences has a rich
history of developing leading technologies in several markets. The
company today is a pure play in global Security,
Safety, and Defense (SS&D) markets. The Company's patented
technology, used
in its flagship product, the Quantum Sniffer™ QS-H150 handheld
explosives trace
detector, is in use throughout the world.
IMSC successfully introduced its first handheld
explosive
trace detection product in 2003 and has sold more than 1,100 ETD
systems,
generating over $25 million in revenues. The global ETD market is
project to grow to approximately $1 billion by 2014.
The
QS-H150 has been Designated a Qualified Anti-Terrorism Technology by
the U.S.
Department of Homeland Security pursuant to 6 U.S.C. § 441-444 (the
Support Anti-terrorism
by Fostering Effective Technologies Act of 2002, or "SAFETY Act") and
6 C.F.R. Part 25 (Regulations to Support Anti-terrorism by Fostering
Effective
Technologies).
|
